Clinical Trials Browser

Bile Duct Neoplasms × olaparib × 90 days × Clear all

NCT04042831 2026-05-15

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

Phase 2 Active not recruiting

32 enrolled 15 charts

Gastrointestinal

Bile Duct Neoplasms